Effective treatment halts HIV transmission among homosexual couples, study finds

July 26, 2017 by Lucienne Bamford
Effective treatment halts HIV transmission among homosexual couples, study finds
Credit: Shutterstock

Results from the largest study to analyse HIV transmission risk among homosexual couples with differing HIV status have shown that HIV positive men who are on treatment that makes the virus undetectable, do not transmit HIV to their partners.

The results from the Kirby Institute's Opposites Attract study were presented today at the IAS Conference on HIV Science in Paris.

During the course of the study, participant couples reported almost 17 thousand acts of anal-intercourse without a condom, none of which resulted in HIV transmission.

"Undetectable virus level effectively prevents HIV transmission among ," said Professor Andrew Grulich from the Kirby Institute and chief investigator on the study.

"Opposites Attract is the first study to show that these results apply in both high and middle income countries. Our research adds to the evidence from a small number of other international studies of heterosexual and homosexual couples and means that we can say, with confidence, that effectively treated HIV blocks transmission in couples of differing HIV status."

HIV treatment works by suppressing the level of virus in a person living with HIV's body, so that immune system damage is halted and even reversed. When treatment is consistently taken daily, the virus levels become so low that they become undetectable in the blood. The results of Opposites Attract show that when an undetectable viral load is maintained, the risk of HIV transmission is negligible.

"This is life-changing news for couples of differing HIV status. But it is important that the HIV positive is under regular medical care and does not miss any of their anti-retroviral medication in order to ensure they maintain an undetectable viral load" said Professor Grulich. "Our data add to previous studies which show that there has never been a recorded case of HIV transmission from an HIV-positive person to their HIV-negative sexual partner when the HIV-positive partner had undetectable viral load."

Opposites Attract was a cohort study of HIV among 358 gay couples in relationships where one partner is HIV positive and the other negative. The study followed participants from Thailand, Brazil and Australia over four years from 2012–2016.

"We are grateful to the participant couples who were involved in the study, as well as our study partners from Evandro Chagas Clinical Research Institute, Fiocruz in Brazil and the Thai Red Cross in Thailand," said Professor Grulich. "The international collaboration made possible through our partnerships adds to the strength and validity of these very exciting study results."

Explore further: Good news for HIV treatment as prevention

Related Stories

Good news for HIV treatment as prevention

March 7, 2014
The Kirby Institute at UNSW Australia welcomes early results from the PARTNER study, which has found that HIV positive gay men who are on treatment and have undetectable viral load are not transmitting HIV to their partners.

Scientists divulge latest in HIV prevention

July 25, 2017
A far cry from the 1990s "ABC" campaign promoting abstinence and monogamy as HIV protection, scientists reported on new approaches Tuesday allowing people to have all the safe sex they want.

Largest HIV transmission study conducted

July 12, 2016
A new study has found that neither gay men nor heterosexual people with HIV transmit the virus to their partner, provided they are on suppressive antiretroviral treatment.

Study examines risk of HIV transmission from condomless sex with virologically suppressed HIV infection

July 12, 2016
Among nearly 900 serodifferent (one partner is HIV-positive, one is HIV-negative) heterosexual and men who have sex with men couples in which the HIV-positive partner was using suppressive antiretroviral therapy and who reported ...

Conception options available for HIV-discordant couples

June 5, 2017
(HealthDay)—Various methods are available for reducing the risk of HIV transmission in HIV-discordant couples who would like to attempt conception, according to research published in the June 2 issue of the U.S. Centers ...

Very low transmission of HIV within couples receiving both ART and PrEP

August 23, 2016
Providing HIV medication to both members of a couple may substantially reduce the risk of transmission within that couple, according to a study in PLOS Medicine.

Recommended for you

Study suggests a way to stop HIV in its tracks

December 1, 2017
When HIV-1 infects an immune cell, the virus travels to the nucleus so quickly there's not enough time to set off the cell's alarm system.

Discovery puts the brakes on HIV's ability to infect

November 30, 2017
Viewed with a microscope, the virus faintly resembles a pineapple—the universal symbol of welcome. But HIV, the virus that causes AIDS, is anything but that. It has claimed the lives of more than 35 million people so far.

Rising levels of HIV drug resistance

November 30, 2017
HIV drug resistance is approaching and exceeding 10% in people living with HIV who are about to initiate or reinitiate first-line antiretroviral therapy, according to the largest meta-analysis to date on HIV drug resistance, ...

Male circumcision and antiviral drugs appear to sharply reduce HIV infection rate

November 29, 2017
A steep drop in the local incidence of new HIV infections accompanied the rollout of a U.S.-funded anti-HIV program in a large East-African population, according to a study led by researchers at Johns Hopkins Bloomberg School ...

Combination HIV prevention reduces new infections by 42 percent in Ugandan district

November 29, 2017
A study published today in the New England Journal of Medicine provides real-world evidence that implementing a combination of proven HIV prevention measures across communities can substantially reduce new HIV infections ...

Research on HIV viral load urges updates to WHO therapy guidelines

November 24, 2017
A large cohort study in South Africa has revealed that that low-level viraemia (LLV) in HIV-positive patients who are receiving antiretroviral treatment (ART) is an important risk factor for treatment failure.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.